Is DRviaSPCN safe to use?

DRviaSPCN has no known vulnerabilities on the latest version (0.1.5). DepScope rates its health at 38/100 (critical risk).

What is the latest version of DRviaSPCN?

The latest version of DRviaSPCN is 0.1.5, released 2025-01-09.

Does DRviaSPCN have known vulnerabilities?

No known vulnerabilities on the latest version of DRviaSPCN.

Is DRviaSPCN deprecated?

No, DRviaSPCN is actively maintained. Latest release: 0.1.5 (2025-01-09).

What are alternatives to DRviaSPCN?

DepScope has no curated alternatives for DRviaSPCN at this time.

What license does DRviaSPCN use?

DRviaSPCN is licensed under GPL (>= 2).

DRviaSPCN

cranv0.1.5

Drug Repurposing in Cancer via a Subpathway Crosstalk Network. A systematic biology tool was developed to repurpose drugs via a subpathway crosstalk network. The operation modes include 1) calculating centrality scores of SPs in the context of gene expression data to reflect the influence of SP crosstalk, 2) evaluating drug-disease reverse association based on

License GPL (>= 2)0 versions1 maintainers6 deps77 weekly dl

https://CRAN.R-project.org/package=DRviaSPCN

/ 100

Health

use with caution

[email protected] low health (38/100) — consider alternatives

Low health score (38/100)

Health breakdown0 – 100

5/25

maintenance

0/20

popularity

25/25

security

6/15

maturity

2/15

community

Vulnerabilities

none known

Health History

Dependency Tree

License Audit

Dependencies (6)

GSVA clusterProfiler graphics igraph pheatmap stats

API access

Get this data programmatically — free, no authentication.

curl https://depscope.dev/api/check/cran/DRviaSPCN

First published · 2025-01-09 11:46:14

Last updated · 2025-01-09T10:20:06+00:00